ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $20,182,000 | -45.4% | 5,742 | -68.2% | 0.00% | – |
| Q4 2016 | $36,947,000 | +4.5% | 18,068 | -10.5% | 0.00% | – |
| Q3 2016 | $35,347,000 | +117.9% | 20,198 | +112.9% | 0.00% | – |
| Q2 2016 | $16,219,000 | -83.7% | 9,485 | -81.9% | 0.00% | – |
| Q4 2015 | $99,450,000 | +4.0% | 52,342 | +4.6% | 0.00% | – |
| Q3 2015 | $95,609,000 | -65.2% | 50,057 | -15.4% | 0.00% | -100.0% |
| Q2 2015 | $274,391,000 | +1203.0% | 59,136 | +1127.1% | 0.00% | – |
| Q1 2015 | $21,059,000 | -93.8% | 4,819 | -76.4% | 0.00% | – |
| Q3 2014 | $339,298,000 | +11209.9% | 20,459 | +3895.9% | 0.00% | – |
| Q2 2014 | $3,000,000 | -99.0% | 512 | -99.1% | 0.00% | – |
| Q3 2013 | $286,725,000 | -53.4% | 54,407 | -32.0% | 0.00% | – |
| Q2 2013 | $615,900,000 | – | 79,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
| Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
| Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
| TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
| ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
| Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
| Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
| Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
| A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |